BranchLab Secures Strategic Investment from Next Ventures
BranchLab, an AI-native healthcare marketing solutions provider, has received a strategic investment from Next Ventures.
BranchLab, an AI-native healthcare marketing solutions provider, has received a strategic investment from Next Ventures.
Investors
Next Ventures is an early-stage venture capital firm dedicated to supporting founders redefining whole-person health. The firm envisions the future of healthcare as a proactive, interconnected ecosystem, one where technology, data, and care converge to empower individuals to take control of their well-being and longevity.
BranchLab Use of Funds
The company will use the funds to scale its AI-powered Pathwai platform, drive adoption among healthcare brands and agencies, and advance its compliance-driven marketing infrastructure.
About BranchLab
BranchLab is an AI-native technology company setting a new standard in privacy-first, outcome-based advertising for the healthcare industry. Its Pathwai platform leverages a compliance-by-design architecture to transform otherwise unrelated datasets into high-value strategic assets. It enables brands, agencies, and media partners to create, activate, and measure audiences optimized for real healthcare outcomes, such as prescriptions, diagnoses, or healthcare visits, using non-health data. BranchLab operates in the United States, with offices in New York, Colorado, and San Francisco.
Funding Details
Company: BranchLab, Inc.
Raised: Undisclosed
Round: Strategic
Funding Date: September 2025
Lead Investor: Next Ventures
Additional Investors:
Company Website: https://branchlab.com/
Software Category: AI Healthcare Marketing / Health Data Platforms
